Related Experiment Videos
X-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation
Vasu Punj1, Hittu Matta, Preet M Chaudhary
1Department of Medicine, Division of Hematology-Oncology, Hillman Cancer Center, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15213-1863, USA. punjv@upmc.edu
Purpose:
The X-linked ectodermal dysplasia receptor (XEDAR) is a novel receptor of the tumor necrosis factor receptor family that binds to ectodysplasin-A2 (EDA-A2) and induces cell death. The purpose of this study was to determine the tumor-suppressive potential of XEDAR in the development of breast cancer.
Experimental Design:
We analyzed the expression of XEDAR in breast cancer cell lines and tumor samples using quantitative real-time PCR analysis and immunoblotting. We analyzed the human XEDAR gene promoter for the presence of any CpG island and examined its methylation status using methylation-specific real-time PCR. We examined the effect of 5-aza-2'-deoxycytidine on the expression of XEDAR and sensitivity to EDA-A2-induced apoptosis in breast cancer cell lines.
Results:
Expression of XEDAR, but not EDA-A2, was downregulated in most tumorigenic breast cancer cell lines and tumor samples. Loss of XEDAR expression correlated with the hypermethylation of its promoter. Ectopic expression of XEDAR in MDA-MB-231 cells resulted in significant induction of apoptosis and reduction in colony formation. Treatment with 5-aza-2'-deoxycytidine restored XEDAR expression in breast cancer cell lines with methylated XEDAR promoter and sensitized them to EDA-A2-induced cell death.
Conclusions:
Our results suggest that XEDAR expression is downregulated in most breast cancers via promoter methylation, which may contribute to accelerated tumor development by blocking EDA-A2-induced cell death. XEDAR may represent a novel breast tumor suppressor gene, and restoration of its expression by treatment with DNA demethylating agents may represent an attractive approach for the treatment of breast cancer.
Insights
X-linked ectodermal dysplasia receptor (XEDAR) is downregulated in breast cancer due to promoter methylation, hindering EDA-A2-induced cell death. Restoring XEDAR may offer a novel breast cancer treatment approach.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The X-linked ectodermal dysplasia receptor (XEDAR) is a tumor necrosis factor receptor family member that binds ectodysplasin-A2 (EDA-A2) and induces apoptosis.
- Understanding XEDAR's role in breast cancer is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the tumor-suppressive potential of XEDAR in breast cancer development.
- To determine if XEDAR downregulation is associated with breast cancer progression.
Main Methods:
- Quantitative real-time PCR and immunoblotting were used to analyze XEDAR expression in breast cancer cell lines and tissues.
- CpG island analysis and methylation-specific PCR assessed the XEDAR gene promoter methylation status.
- The effect of 5-aza-2'-deoxycytidine on XEDAR expression and apoptosis sensitivity was examined.
Main Results:
- XEDAR expression was downregulated in most breast cancer cell lines and tumor samples, unlike EDA-A2.
- Loss of XEDAR expression correlated with hypermethylation of its promoter.
- Ectopic XEDAR expression induced apoptosis and reduced colony formation in MDA-MB-231 cells.
- 5-aza-2'-deoxycytidine treatment restored XEDAR expression and sensitized cells to EDA-A2-induced apoptosis.
Conclusions:
- XEDAR is downregulated in breast cancer via promoter methylation, potentially promoting tumor development by inhibiting EDA-A2-induced cell death.
- XEDAR functions as a novel breast tumor suppressor gene.
- Restoring XEDAR expression using DNA demethylating agents presents a potential therapeutic strategy for breast cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Hedgehog Signaling Pathway